Chromenopyrimidine derivatives as phosphatidylinsitol phosphate kinase inhibitors
US11498929B2 · kind B2 · utility
0Cited by
2References
13Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 17, 2020 |
| Grant date | Nov 15, 2022 |
| Priority date | — |
| Expiry date | Jun 17, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D493/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention relates to inhibitors of PI5P4K inhibitors useful in the treatment of cancers, neurodegenerative diseases, inflammatory disorders, and metabolic diseases, having the Formula: where A1, A2, G, R1, R2, R3, R4, and W are described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.